NL300302I2 - Antivirale verbindingen. - Google Patents

Antivirale verbindingen.

Info

Publication number
NL300302I2
NL300302I2 NL300302C NL300302C NL300302I2 NL 300302 I2 NL300302 I2 NL 300302I2 NL 300302 C NL300302 C NL 300302C NL 300302 C NL300302 C NL 300302C NL 300302 I2 NL300302 I2 NL 300302I2
Authority
NL
Netherlands
Prior art keywords
antiviral compounds
compounds
prophylaxis
processes
pharmaceutically acceptable
Prior art date
Application number
NL300302C
Other languages
English (en)
Other versions
NL300302I1 (nl
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL300302I1 publication Critical patent/NL300302I1/nl
Publication of NL300302I2 publication Critical patent/NL300302I2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
NL300302C 1987-05-30 2007-11-02 Antivirale verbindingen. NL300302I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712745A GB8712745D0 (en) 1987-05-30 1987-05-30 Antiviral compounds

Publications (2)

Publication Number Publication Date
NL300302I1 NL300302I1 (nl) 2008-01-02
NL300302I2 true NL300302I2 (nl) 2008-05-01

Family

ID=10618179

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300302C NL300302I2 (nl) 1987-05-30 2007-11-02 Antivirale verbindingen.

Country Status (31)

Country Link
US (2) US5424295A (nl)
EP (1) EP0294114B1 (nl)
JP (1) JP2667873B2 (nl)
KR (1) KR970009474B1 (nl)
CN (1) CN1020107C (nl)
AT (1) ATE142636T1 (nl)
AU (1) AU622403B2 (nl)
CA (1) CA1330990C (nl)
CS (1) CS277006B6 (nl)
CY (2) CY2001A (nl)
DD (2) DD293962A5 (nl)
DE (2) DE122008000003I2 (nl)
DK (1) DK171670B1 (nl)
ES (1) ES2091750T3 (nl)
FI (1) FI89805C (nl)
GB (1) GB8712745D0 (nl)
GR (1) GR3021257T3 (nl)
HK (1) HK78497A (nl)
HU (2) HU205001B (nl)
IL (1) IL86531A (nl)
LU (1) LU91370I2 (nl)
MC (1) MC1935A1 (nl)
MY (1) MY103567A (nl)
NL (1) NL300302I2 (nl)
NO (2) NO172543C (nl)
NZ (1) NZ224813A (nl)
PH (1) PH27292A (nl)
PL (1) PL157684B1 (nl)
PT (1) PT87592B (nl)
SA (1) SA99200688A (nl)
ZA (2) ZA883829B (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
US6337209B1 (en) 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
KR910007655A (ko) * 1989-10-03 1991-05-30 엠. 피. 잭슨 치료용 뉴클레오시드
US5206351A (en) * 1990-06-15 1993-04-27 Ash Stevens, Inc. Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5283331A (en) * 1990-12-20 1994-02-01 Nippon Kayaku Kabushiki Kaisha 2-halogeno-oxetanocin A and phosphoric ester thereof
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
JP3619017B2 (ja) 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
US6653318B1 (en) * 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
NZ520852A (en) * 2000-02-18 2004-03-26 Southern Res Inst Intermediates and methods for synthesizing 2-chloro-9- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
US6753322B2 (en) * 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
KR100718371B1 (ko) * 2001-11-27 2007-05-14 애나디스 파마슈티칼스, 인코포레이티드 3-β-D-리보푸라노실티아졸로[4,5-d]피리디민누클레오시드 및 이의 용도
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
TW200418498A (en) * 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
PL2561872T3 (pl) 2004-12-17 2015-03-31 Anadys Pharmaceuticals Inc 3,5-Dipodstawione oraz 3,5,7-tripodstawione związki 3H-oksazolo[4,5-d]pirymidyn-2-onowe i ich proleki
US20060178512A1 (en) * 2005-02-04 2006-08-10 Cheruthur Govindan Method for preparing amino acid esters of nucleoside analogues
TWI383987B (zh) 2005-11-21 2013-02-01 Anadys Pharmaceuticals Inc 製備5-胺基-3H-噻唑并〔4,5-d〕嘧啶-2-酮之新穎方法
JP5345527B2 (ja) * 2006-06-22 2013-11-20 アナディス ファーマシューティカルズ インク プロドラッグである5−アミノ−3−(3’−デオキシ−β−D−リボフラノシル)−チアゾロ[4,5−d]ピリミジン−2,7−ジオン
EP2040712B1 (en) 2006-07-18 2011-03-02 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
CN101092441A (zh) * 2007-07-17 2007-12-26 北京本草天源药物研究院 一种奈拉滨的合成方法
US7846912B2 (en) * 2007-09-13 2010-12-07 Protia, Llc Deuterium-enriched nelarabine
CN101768197A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 一种奈拉滨的制备方法
CN103665076B (zh) * 2012-08-30 2018-01-09 上海阳帆医药科技有限公司 奈拉滨的制备方法
CN104892709B (zh) * 2015-06-04 2018-01-19 新乡学院 一种合成奈拉滨的方法
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm
WO2022258014A1 (zh) * 2021-06-09 2022-12-15 正大天晴药业集团股份有限公司 用于制备奈拉滨的重组基因工程菌及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
US3758684A (en) * 1971-09-07 1973-09-11 Burroughs Wellcome Co Treating dna virus infections with amino purine derivatives
US4055717A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(3-O-Acyl-β-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-β-D-arabinofuranosyl)-adenine compounds, and method for their production
US4055718A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(2-O-Acyl-β-D-arabinofuranosyl)-adenine compounds and method for their production
US4048432A (en) * 1976-05-17 1977-09-13 Parke, Davis & Company 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production
JPS5515716A (en) * 1978-07-18 1980-02-04 Ajinomoto Co Inc Production of purine arabinoside
US4371613A (en) * 1977-08-10 1983-02-01 Ajinomoto Company Incorporated Method for producing purine arabinosides
JPS6053941B2 (ja) * 1977-08-10 1985-11-28 日本電気株式会社 バイアスライト駆動方式
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド5′−アルキルもしくはアルケニルりん酸
EP0199451B1 (en) * 1985-03-16 1996-03-06 The Wellcome Foundation Limited Therapeutic nucleosides
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
NZ224813A (en) 1991-04-26
DE122008000003I1 (de) 2008-04-17
GB8712745D0 (en) 1987-07-01
NL300302I1 (nl) 2008-01-02
EP0294114B1 (en) 1996-09-11
FI89805C (fi) 1993-11-25
DD282694A5 (de) 1990-09-19
GR3021257T3 (en) 1997-01-31
DK289788D0 (da) 1988-05-27
KR880013967A (ko) 1988-12-22
HU895829D0 (en) 1990-01-28
JP2667873B2 (ja) 1997-10-27
PL157684B1 (pl) 1992-06-30
FI882511A0 (fi) 1988-05-27
EP0294114A3 (en) 1990-01-24
HK78497A (en) 1997-06-20
PT87592A (pt) 1989-05-31
HUT47129A (en) 1989-01-30
CY2001A (en) 1997-12-05
PH27292A (en) 1993-05-04
ES2091750T3 (es) 1996-11-16
JPS63310831A (ja) 1988-12-19
IL86531A0 (en) 1988-11-15
CN1020107C (zh) 1993-03-17
CN1031233A (zh) 1989-02-22
CS8803635A2 (en) 1990-09-12
ZA883829B (en) 1990-01-31
NO172543C (no) 1993-08-04
NO172543B (no) 1993-04-26
NO882357D0 (no) 1988-05-27
PT87592B (pt) 1992-09-30
ATE142636T1 (de) 1996-09-15
DK289788A (da) 1988-12-01
PL272729A1 (en) 1989-02-06
IL86531A (en) 1993-07-08
SA99200688A (ar) 2005-12-03
US5424295A (en) 1995-06-13
HU199870B (en) 1990-03-28
DK171670B1 (da) 1997-03-10
DE122008000003I2 (de) 2010-02-04
FI89805B (fi) 1993-08-13
US5539098A (en) 1996-07-23
CY2008001I2 (el) 2009-11-04
NO2007016I2 (no) 2008-06-23
CS277006B6 (en) 1992-11-18
ZA897598B (en) 1990-01-31
KR970009474B1 (ko) 1997-06-13
DE3855522T2 (de) 1997-02-06
NO2007016I1 (no) 2008-01-14
LU91370I2 (fr) 2007-12-10
EP0294114A2 (en) 1988-12-07
FI882511A (fi) 1988-12-01
DE3855522D1 (de) 1996-10-17
AU622403B2 (en) 1992-04-09
CA1330990C (en) 1994-07-26
AU1671888A (en) 1988-12-01
DD293962A5 (de) 1991-09-19
MY103567A (en) 1993-08-28
CY2008001I1 (el) 2009-11-04
NO882357L (no) 1988-12-01
MC1935A1 (fr) 1989-05-19
HU205001B (en) 1992-03-30

Similar Documents

Publication Publication Date Title
NL300302I1 (nl) Antivirale verbindingen.
ATE63747T1 (de) Antivirale verbindungen.
ZA898926B (en) Antiviral compounds